Faster Improvement in Migraine Pain Intensity and Migraine‐Related Disability at Early Time Points with AVP‐825 (Sumatriptan Nasal Powder Delivery System) versus Oral Sumatriptan: A Comparative Randomized Clinical Trial Across Multiple Attacks from the COMPASS Study
Richard B. Lipton; James S. McGinley; Kenneth J. Shulman; R.J. Wirth; Dawn C. Buse
Author Information: Department of Neurology Albert Einstein College of Medicine and Montefiore Headache Center
|Checking for direct PDF access through Ovid|
Abstract unavailable for this article.